Monument Therapeutics develops treatments for cognitive symptoms of schizophrenia and other psychiatric and neurological conditions.

Atelerix develops hypothermic preservation technology for storing and transporting biological samples at ambient temperatures, reducing costs and carbon emissions compared to traditional methods.

ViaNautis Bio specializes in nano-engineered polymer technology, PolyNaut®, which enables targeted intracellular delivery of therapeutic payloads.

Kuano is a drug discovery company that uses a quantum simulation platform to model enzymes in their dynamic state for more precise drug design, with a focus on diseases like bowel cancer and lymphoma.